2017-06-292026-03-272017-06-292003José Artemio Hernández Martínez1540-9996https://doi.org/10.1089/154099903321154121https://repositorio.inprf.gob.mx/handle/123456789/5087engacceso cerradoFailure of tibolone to potentiate the pharmacological effect of fluoxetine in postmenopausal major depressionarticle1Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz33-39Estados Unidos21AgedDepressive Disorderblooddrug therapyDouble-Blind MethodEstrogen Receptor Modulatorstherapeutic useEstrogensFemaleFluoxetinetherapeutic useHumansMexicoMiddle AgedNorpregnenesPostmenopauseSerotonin Uptake Inhibitors